Dermot Dolan is Group Chief Technology Officer and dedicated 100% to the USA opportunity for the foreseeable future. One of the founding team of Socrates, he has a BSC in Computing in Business from Sligo Institute of Technology. Dermot’s major interests include application architecture be it object models/ UML/ High Level Design in a client/server or SaaS solution. His main interest in work is to move to the cloud, real world and hybrid clouds v

Elaine Brennan was appointed CEO of Socrates Healthcare Inc in April 2011 and based in New York has responsibility for the sale and marketing of Yeats Clinical, both Directly to Users and through resellers. She manages the Sales process through contract sales team in operation since March 2011, and key Socrates IRL executives seconded to USA. She also has responsibility for product development through CTO Dermot Dolan and a team of internal and o

Colin O’Connor is Chief Operations Officer with Socrates Healthcare, a position he has held since 2007. He graduated from Sligo IT with a BSC in Computing in Business in 2004 and is one of the original 3 founding team. He was a developer for 3 years with Socrates Healthcare on the Socrates GP program. From 2007 to 2009 he was Technical Manager with Socrates. He is managing operations in Ireland, and has been instrumental in bringing the USA

Michael Lucitt has many years experience in chief executive management roles with a number of organisations. As Finance Director of Irish Cable and Wire from 1977 to 1984 and as Managing Director to 1993 he led the business through a number of phases including the establishment of Joint Venture Customer partners and establishment of alliances with International partners, leading to the eventual sale of the business to Alcatel in 1991. He joined

Tony is Chairman and a founding member of the business. He is a General Practitioner. He is a senior partner of a large medical GP
practice in Athlone and through collaboration between him, his colleagues and Socrates developers, Socrates GP was established,
piloted and rened before launching on the general market in 2005. He continues to be instrumental in the development of
product features and advises Socrates from a medical user perspecti